Pioneering Medicines 02, LLC 3
3 · Generate Biomedicines, Inc. · Filed Mar 12, 2026
Insider Transaction Report
Form 3
Pioneering Medicines 02, LLC
10% Owner
Holdings
- 1,562,500(indirect: By LLC)
Common Stock
[F1]
Footnotes (1)
- [F1]Securities held by Pioneering Medicines 02, LLC ("PM02"). Charles R. Carelli, Jr., Chief Financial Officer of Flagship Pioneering, LLC ("Flagship Pioneering"), is the sole manager of PM02, and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") is its majority equity holder. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the ultimate control person of Flagship Pioneering. The Reporting Person disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any.
Signature
Pioneering Medicines 02, LLC, By: /s/ Charles R. Carelli, Jr., Manager|2026-03-12